Cargando…

Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Neuromuscular blocking agent (NMBA) has been proposed by medical guidelines for early severe acute respiratory distress syndrome (ARDS) because of its survival benefits. However, new studies have provided evidence contradicting these results. METHOD: A search was performed of the Pubmed,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, An Thi Nhat, Patolia, Setu, Guervilly, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986163/ https://www.ncbi.nlm.nih.gov/pubmed/32015880 http://dx.doi.org/10.1186/s40560-020-0431-z

Ejemplares similares

Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
por: Zheng, Zhongjun, et al.
Publicado: (2020)

Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome
por: Rudolph, Michelle W., et al.
Publicado: (2022)

Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
por: Tarazan, Nehal, et al.
Publicado: (2020)

A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome
por: Macario, Alex, et al.
Publicado: (2006)

Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome
por: Shanholtz, Carl B., et al.
Publicado: (2023)

Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis
por: Hua, Yusi, et al.
Publicado: (2020)

Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Alhazzani, Waleed, et al.
Publicado: (2013)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Neuromuscular blockade is associated with the attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome
por: Sottile, Peter D., et al.
Publicado: (2018)

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
por: Wei, Xue-biao, et al.
Publicado: (2020)

Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
por: Chang, Wei, et al.
Publicado: (2020)

Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression
por: Shao, Shuai, et al.
Publicado: (2020)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Bronchoscopy in intubated and non-intubated intensive care unit patients with respiratory failure
por: Patolia, Setu, et al.
Publicado: (2021)

Effect of high-frequency oscillatory ventilation on esophageal and transpulmonary pressures in moderate-to-severe acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2016)

Assessment of Airway Closure and Expiratory Airflow Limitation to Set Positive End-Expiratory Pressure in Morbidly Obese Patients with Acute Respiratory Distress Syndrome
por: Mezidi, Mehdi, et al.
Publicado: (2021)

High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2011)

EFFECT OF CORTICOSTEROIDS ON NOSOCOMIAL INFECTIONS IN PATIENTS WITH COVID-19, A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS
por: SHARAYAH, AHMAD, et al.
Publicado: (2021)

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
por: van de Veerdonk, Frank L, et al.
Publicado: (2020)

Blockade of caspase cascade overcomes malaria-associated acute respiratory distress syndrome in mice
por: Sercundes, Michelle K., et al.
Publicado: (2022)

Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis
por: Papazian, Laurent, et al.
Publicado: (2022)

Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer
por: Kanchustambham, Venkatkiran, et al.
Publicado: (2017)

Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
por: Hamon, Annabelle, et al.
Publicado: (2019)

Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
por: Torbic, Heather, et al.
Publicado: (2019)

Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center
por: Roch, Antoine, et al.
Publicado: (2013)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Pereira, VGM
Publicado: (2013)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Neto, Ary Serpa, et al.
Publicado: (2012)

Corticosteroid treatment for early acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials
por: Hirano, Yohei, et al.
Publicado: (2020)

Effectiveness of neuromuscular electrical stimulation in severe acute pancreatitis complicated patients with acute respiratory distress syndrome: study protocol for a randomized controlled trial
por: Zhou, Feng, et al.
Publicado: (2023)

Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome
por: Forel, Jean-Marie, et al.
Publicado: (2018)

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
por: Courcelle, Romain, et al.
Publicado: (2020)

Sex-differences in the longitudinal recovery of neuromuscular function in COVID-19 associated acute respiratory distress syndrome survivors
por: Lulic-Kuryllo, Tea, et al.
Publicado: (2023)

Cardiac biomarkers in acute respiratory distress syndrome: a systematic review and meta-analysis
por: Jayasimhan, Dilip, et al.
Publicado: (2021)

Dexamethasone for the treatment of acute respiratory distress syndrome: A systematic review and meta-analysis
por: Feng, Long-hua, et al.
Publicado: (2022)

Inhaled Prostacyclins for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: Torbic, Heather, et al.
Publicado: (2023)

Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis
por: Ruan, Sheng-Yuan, et al.
Publicado: (2014)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
por: Chiles, Kris T, et al.
Publicado: (2011)

Acute respiratory distress syndrome.
por: Lunn, J. J., et al.
Publicado: (1998)

Acute respiratory distress syndrome
por: Matthay, Michael A., et al.
Publicado: (2019)

Acute respiratory distress syndrome
por: Chen, Hsing I., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_5meolinlm59j84o1acr1hu9nn8